Crossmark

The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma

Published Online: 2025-04-19

Authors

Zhang, Yifan

Zhang, Shengli

Sun, Hongbin

Xu, Luwei https://orcid.org/0000-0002-6838-5563
Funding

Funding for this research was provided by:

Traditional Chinese Medicine Technology Development Plan Project of Jiangsu Province
License Information

Text and Data Mining valid from 2025-04-19

Version of Record valid from 2025-04-19
More Information

Article History

Received: 17 November 2024

Revised: 29 March 2025

Accepted: 4 April 2025

First Online: 19 April 2025

Competing interests

: The authors declare no competing interests.

Document is current